Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis

Stem Cells and Development

Volumn 21, Issue 6, 2012, Pages 846-858

  Alberton, Paolo ^a   Popov, Cvetan ^a   Prägert, Markus ^a   Kohler, Julia ^a   Shukunami, Chisa ^b   Schieker, Matthias ^a   Docheva, Denitsa ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ALPHA SMOOTH MUSCLE ACTIN; AP2 PROTEIN; BIGLYCAN; BSP PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 14; COLLAGEN TYPE 15; COLLAGEN TYPE 3; COMP PROTEIN; COMPLEMENTARY DNA; HERMES ANTIGEN; LENTIVIRUS VECTOR; LUMICAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; PROTEOGLYCAN; TENASCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR SCLERAXIS; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; BONE MARROW; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CELL TRANSFORMATION; CLONOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; TENDON; TENDON PROGENITOR CELL; TRANSGENE; UPREGULATION;

ADIPOGENESIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL DIFFERENTIATION; GENE EXPRESSION; HUMANS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; TENDONS;

EID: 84859377373     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0150     Document Type: Article

References (49)

1. Benjamin M, E Kaiser and S Milz. (2008). Structure-function relationships in tendons: a review. J Anat 212:211-228.
2. Kjaer M. (2004). Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84:649-698.
3. Brent AE, R Schweitzer and CJ Tabin. (2003). A somitic compartment of tendon progenitors. Cell 113:235-248.
4. Tozer S and D Duprez. (2005). Tendon and ligament: development, repair and disease. Birth Defects Res C Embryo Today 75:226-236.
5. Schweitzer R, JH Chyung, LC Murtaugh, AE Brent, V Rosen, EN Olson, A Lassar and CJ Tabin. (2001). Analysis of the tendon cell fate using scleraxis, a specific marker for tendons and ligaments. Development 128:3855-3866.
6. Cserjesi P, D Brown, KL Ligon, GE Lyons, NG Copeland, DJ Gilbert, NA Jenkins and EN Olson. (1995). Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 121:1099-1110.
7. Carlberg AL, RS Tuan and DJ Hall. (2000). Regulation of scleraxis function by interaction with the bHLH protein E47. Mol Cell Biol Res Commun 3:82-86.
8. Furumatsu T, C Shukunami, M Amemiya-Kudo, H Shimano and T Ozaki. (2010). Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription. Int J Biochem Cell Biol 42:148-156.
9. Liu Y, H Watanabe, A Nifuji, Y Yamada, EN Olson and M Noda. (1997). Overexpression of a single helix-loop-helixtype transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem 272:29880-29885.
10. Terraz C, G Brideau, P Ronco and J Rossert. (2002). A combination of cis-acting elements is required to activate the pro-alpha 1(I) collagen promoter in tendon fibroblasts of transgenic mice. J Biol Chem 277:19019-19026.
11. Shukunami C, A Takimoto, M Oro and Y Hiraki. (2006). Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol 298:234-247.
12. Lejard V, G Brideau, F Blais, R Salingcarnboriboon, G Wagner, MH Roehrl, M Noda, D Duprez, P Houillier and J Rossert. (2007). Scleraxis and NFATc regulate the expression of the pro-alpha1(I) collagen gene in tendon fibroblasts. J Biol Chem 282:17665-17675.
13. Espira L, L Lamoureux, SC Jones, RD Gerard, IM Dixon and MP Czubryt. (2009). The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis. J Mol Cell Cardiol 47:188-195.
14. MurchisonND, BAPrice,DAConner,DRKeene, ENOlson,CJ Tabin and R Schweitzer. (2007). Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development 134:2697-2708.
15. Brandau O, A Meindl, R Fassler and A Aszodi. (2001). A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin- I. Dev Dyn 221:72-80.
16. Shukunami C, Y Oshima and Y Hiraki. (2001). Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem Biophys Res Commun 280:1323-1327.
17. Docheva D, EB Hunziker, R Fassler and O Brandau. (2005). Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 25:699-705.
18. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
19. Alhadlaq A and JJ Mao. (2004). Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13:436-448.
20. da Silva ML, AI Caplan and NB Nardi. (2008). In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287-2299.
21. Krampera M, G Pizzolo, G Aprili and M Franchini. (2006). Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 39:678-683.
22. Drosse I, E Volkmer, R Capanna, P De Biase, W Mutschler and M Schieker. (2008). Tissue engineering for bone defect healing: an update on a multi-component approach. Injury 39 (Suppl. 2):S9-S20.
23. Boker W, Z Yin, I Drosse, F Haasters, O Rossmann, M Wierer, C Popov, M Locher,WMutschler, D Docheva andM Schieker. (2008). Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med 12:1347-1359.
24. Huang GT, K Shagramanova and SW Chan. (2006). Formation of odontoblast-like cells from cultured human dental pulp cells on dentin in vitro. J Endod 32:1066-1073.
25. Bocker W, O Rossmann, D Docheva, G Malterer, W Mutschler and M Schieker. (2007). Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells. J Gene Med 9:585-595.
26. Mueller MB, M Fischer, J Zellner, A Berner, T Dienstknecht, L Prantl, R Kujat, M Nerlich, RS Tuan and P Angele. (2010). Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs 192:158-166.
27. Docheva D, D Padula, C Popov, P Weishaupt, M Pragert, N Miosge, R Hickel, W Bocker, H Clausen-Schaumann and M Schieker. (2010). Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titaniumsurface. EurCellMater 19:228-241.
28. Weiler A, G Peters, J Maurer, FN Unterhauser and NP Sudkamp. (2001). Biomechanical properties and vascularity of an anterior cruciate ligament graft can be predicted by contrast-enhanced magnetic resonance imaging. A two-year study in sheep. Am J Sports Med 29:751-761.
29. Asou Y, A Nifuji, K Tsuji, K Shinomiya, EN Olson, P Koopman and M Noda. (2002). Coordinated expression of scleraxis and Sox9 genes during embryonic development of tendons and cartilage. J Orthop Res 20:827-833.
30. Komori T. (2010). Regulation of osteoblast differentiation by runx2. Adv Exp Med Biol 658:43-49.
31. Hong JH, ES Hwang, MT McManus, A Amsterdam, Y Tian, R Kalmukova, E Mueller, T Benjamin, BM Spiegelman, et al. (2005). TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074-1078.
32. Rosen ED, P Sarraf, AE Troy, G Bradwin, K Moore, DS Milstone, BM Spiegelman and RM Mortensen. (1999). PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617.
33. Bi Y, D Ehirchiou, TM Kilts, CA Inkson, MC Embree, W Sonoyama, L Li, AI Leet, BM Seo, et al. (2007). Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13:1219-1227.
34. Barzilay R, E Melamed and D Offen. (2009). Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells 27: 2509-2515.
35. Yamanaka S and HM Blau. (2010). Nuclear reprogramming to a pluripotent state by three approaches. Nature 465: 704-712.
36. Hanna JH, K Saha and R Jaenisch. (2010). Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143:508-525.
37. Ieda M, JD Fu, P Delgado-Olguin, V Vedantham, Y Hayashi, BG Bruneau and D Srivastava. (2010). Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-386.
38. He Z, H Li, S Zuo, Z Pasha, Y Wang, Y Yang, W Jiang, M Ashraf and M Xu. (2011). Transduction of Wnt11 promotesmesenchymal stem cells transdifferentiation into cardiac phenotypes. Stem Cells Dev [Epub ahead of print]; DOI: 10.1089/scd.2010.0380.
39. Szabo E, S Rampalli, RM Risueno, A Schnerch, R Mitchell, A Fiebig-Comyn, M Levadoux-Martin and M Bhatia. (2010). Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468:521-526.
40. Barzilay R, T Ben Zur, S Bulvik, E Melamed and D Offen. (2009). Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev 18:591-601.
41. Brent AE, T Braun and CJ Tabin. (2005). Genetic analysis of interactions between the somiticmuscle, cartilage and tendon cell lineages during mouse development. Development 132:515-528.
42. Hoffmann A and G Gross. (2006). Tendon and ligament engineering: from cell biology to in vivo application. Regen Med 1:563-574.
43. Haddad-Weber M, P Prager, M Kunz, L Seefried, F Jakob, MM Murray, CH Evans, U Noth and AF Steinert. (2010). BMP12 and BMP13 gene transfer induce ligamentogenic differentiation in mesenchymal progenitor and anterior cruciate ligament cells. Cytotherapy 12:505-513.
44. Wang QW, ZL Chen and YJ Piao. (2005). Mesenchymal stem cells differentiate into tenocytes by bone morphogenetic protein (BMP) 12 gene transfer. J Biosci Bioeng 100:418-422.
45. Lou J, Y Tu, FJ Ludwig, J Zhang and PR Manske. (1999). Effect of bone morphogenetic protein-12 gene transfer on mesenchymal progenitor cells. Clin Orthop Relat Res 333-339.
46. Hoffmann A, G Pelled, G Turgeman, P Eberle, Y Zilberman, H Shinar, K Keinan-Adamsky, A Winkel, S Shahab, et al. (2006). Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest 116:940-952.
47. Zhang J and JH Wang. (2010). Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 11:10.
48. Yao L, CS Bestwick, LA Bestwick, N Maffulli and RM Aspden. (2006). Phenotypic drift in human tenocyte culture. Tissue Eng 12:1843-1849.
49. Gulotta LV, D Kovacevic, JD Packer, XH Deng and SA Rodeo. (2011). Bone marrow-derived mesenchymal stem cells transduced with scleraxis improve rotator cuff healing in a rat model. Am J Sports Med 39:1282-1289.